TFIN Q1 2026 Earnings Strong EPS Beat Despite Limited Revenue Disclosure BioLineRx Ltd BLRX Q3 2024 Earnings Narrowed Losses and Pipeline Progress Amidst Low Revenue TD Q1 2026 Earnings EPS Beat Bolsters Investor Confidence Amidst Ongoing Regulatory Challenges CAI Earnings Overview 20260527 Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses SSYS Q1 2026 Earnings NarrowerthanExpected Loss Drives Optimism